The company has not filed an annual or quarterly report since its Q2 FY2017 10-Q, filed Aug 3, 2017. Its latest SEC filing is a SC 13G/A from Feb 14, 2018.
10-Q for Q2 FY2017, filed Aug 3, 2017
The sections below describe the company as of the FY2016 annual report.
Sells rapid diagnostic tests and patient-monitoring products for infectious, cardiometabolic and toxicology conditions to healthcare providers and patients.
10-K for FY2016, filed Jun 5, 2017Alere delivers reliable and actionable health information through rapid diagnostic tests, resulting in better clinical and economic…View ↗
Our professional diagnostic solutions allow patients and their healthcare providers to work together to better manage patients’ conditions…View ↗
In the market for rapid diagnostic products, the ability to deliver faster, accurate results at competitive prices generally drives demand.…View ↗
Hospitals, reference laboratories and physician offices buy professional products through Alere’s sales force or third-party distributors. Arriva Medical mails diabetes supplies to patients; most consumer diagnostic products are sold to SPD for retail sale.
10-K for FY2016, filed Jun 5, 2017We distribute our professional diagnostic products to hospitals, reference laboratories, physician offices and other point-of-care settings…View ↗
Methods of Distribution and CustomersView ↗
Consumer Diagnostics. Substantially all of our consumer diagnostic products are sold to SPD, our joint venture. These products are sold by…View ↗
10-Q for Q2 FY2017, filed Aug 3, 2017
−$93.1MView ↗
8-K, filed Oct 3, 2017
On August 25, 2017, notice was given to holders of Alere’s 6.375% Senior Subordinated Notes due 2023 (the “2023 Notes”) issued by Alere…View ↗
8-K, filed Sep 19, 2017
As previously reported by Alere Inc., a Delaware corporation (the “Company”) on the Form 8-K filed with the Securities and Exchange…View ↗
8-K, filed Jul 21, 2017
On July 21, 2017, Alere Inc. (the “Company”) entered into a Purchase Agreement (the “Epocal Purchase Agreement”) with Siemens Diagnostics…View ↗
8-K, filed Jul 17, 2017
On July 15, 2017, Alere Inc. (the “Company”) entered into a Purchase Agreement (the “Triage Purchase Agreement”) with, solely for purposes…View ↗
From connected health to diagnostics
The older report described diagnostics alongside health information software, clinical decision tools and care programs. The latest report emphasizes rapid diagnostic tests and says Alere sold its health management business.
10-K for FY2013, filed Mar 3, 2014 10-K for FY2016, filed Jun 5, 2017
Competes with Becton Dickinson, Abbott, Danaher, Ortho-Clinical Diagnostics, Roche, Siemens, Meridian Bioscience, Quidel, Trinity, Hologic, INOVA Diagnostics, DiaSorin, Diamedix, Remel, Biokit, Bio-Rad Laboratories, Immuno Concepts, Instrumentation Laboratories, Nova Medical, and Radiometer
10-K for FY2016, filed Jun 5, 2017Professional Diagnostics. Our professional diagnostics products are primarily point-of-care rapid diagnostic testing products sold into the…View ↗
Loading...
